Zhenwei Peng Selected Research

Zhenwei Peng Research Topics

Disease

37	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 02/2012
29	Neoplasms (Cancer) 04/2024 - 02/2012
8	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2012
5	Thrombosis (Thrombus) 04/2024 - 01/2018
2	Cholangiocarcinoma 04/2024 - 03/2016
2	Fibrosis (Cirrhosis) 02/2024 - 01/2018
2	Disease Progression 02/2024 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 06/2017
1	Hand-Foot Syndrome 04/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024
1	Adenocarcinoma 01/2023
1	COVID-19 11/2022
1	Neutropenia 11/2022
1	Nasopharyngeal Carcinoma 11/2022
1	Diarrhea 11/2022
1	Hypopharyngeal Neoplasms 09/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Necrosis 10/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Hypertrophy 03/2020
1	Liver Neoplasms (Liver Cancer) 09/2019
1	Non-Muscle Invasive Bladder Neoplasms 11/2018
1	Shock 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 06/2017

Drug/Important Bio-Agent (IBA)

4	Sorafenib (BAY 43-9006)FDA Link 04/2024 - 01/2018
2	camrelizumabIBA 04/2024 - 01/2023
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2022
2	lenvatinibIBA 01/2023 - 01/2023
2	Glutathione (Reduced Glutathione)IBA 10/2022 - 01/2022
2	Free RadicalsIBA 10/2022 - 10/2022
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2012
2	apatinibIBA 11/2019 - 03/2016
2	Ethanol (Ethyl Alcohol)IBA 11/2018 - 09/2018
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2012
1	Competitive Endogenous RNAIBA 05/2024
1	GS-444217IBA 02/2024
1	AmmoniaIBA 02/2024
1	CollagenIBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	Mitochondrial DNA (mtDNA)IBA 02/2024
1	Thioacetamide (Thioacetamid)IBA 02/2024
1	sintilimabIBA 02/2024
1	Bevacizumab (Avastin)FDA Link 02/2024
1	Liposomes (Liposome)IBA 12/2023
1	PTC-209IBA 12/2023
1	MethyltransferasesIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	COVID-19 VaccinesIBA 11/2022
1	Fluorouracil (Carac)FDA LinkGeneric 11/2022
1	Cisplatin (Platino)FDA LinkGeneric 11/2022
1	Docetaxel (Taxotere)FDA Link 11/2022
1	Hydroxyl RadicalIBA 10/2022
1	ferroceneIBA 10/2022
1	Lipid PeroxidesIBA 10/2022
1	LipidsIBA 10/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Nicorandil (SG 75)IBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	CalreticulinIBA 10/2021
1	Interferon-gamma (Interferon, gamma)IBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Therapeutic UsesIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	gadolinium ethoxybenzyl DTPA FDA Link 09/2019
1	thiamine triphosphorate (TTP)IBA 01/2018
1	NucleotidesIBA 01/2018
1	PhosphoproteinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 06/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016
1	HMGB1 Protein (HMG1)IBA 07/2012
1	Anesthetics (Anesthetic Agents)IBA 02/2012

Therapy/Procedure

18	Radiofrequency Ablation 12/2023 - 01/2012
16	Therapeutics 04/2024 - 12/2016
10	Radiotherapy 05/2024 - 01/2021
7	Hepatectomy 04/2023 - 07/2012
4	Immunotherapy 01/2022 - 11/2018
3	Drug Therapy (Chemotherapy) 01/2023 - 03/2020
1	Combination Drug Therapy (Combination Chemotherapy) 04/2024
1	Induction Chemotherapy 11/2022
1	Chemoradiotherapy 11/2022
1	Photothermal Therapy 10/2022
1	Precision Medicine 10/2022
1	Photochemotherapy (Photodynamic Therapy) 10/2022
1	Immunomodulation 01/2022
1	Nephrectomy 01/2018
1	Treatment Delay 03/2016
1	Aftercare (After-Treatment) 01/2013
1	Conduction Anesthesia (Regional Anesthesia) 02/2012
1	General Anesthesia 02/2012